PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy
Authors
Keywords
Biomarker, Carcinoid, Liquid biopsy, Neuroendocrine, Prediction, PRRT
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 45, Issue 7, Pages 1155-1169
Publisher
Springer Nature
Online
2018-02-27
DOI
10.1007/s00259-018-3967-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The safety of available treatments options for neuroendocrine tumors
- (2017) A. Faggiano et al. Expert Opinion On Drug Safety
- Therapy: The role of liquid biopsies to manage and predict PRRT for NETs
- (2017) Mark Kidd et al. Nature Reviews Gastroenterology & Hepatology
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents
- (2017) Marianne Pavel et al. NEUROENDOCRINOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radionuclide Therapy for Neuroendocrine Tumors
- (2017) Mauro Cives et al. Current Oncology Reports
- An FDA Perspective on the Regulatory Implications of Complex Signatures to Predict Response to Targeted Therapies
- (2016) Julia A. Beaver et al. CLINICAL CANCER RESEARCH
- Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE
- (2016) Maddalena Sansovini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer
- (2016) Lisa Bodei et al. SEMINARS IN NUCLEAR MEDICINE
- Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests
- (2016) Andrew J Vickers et al. BMJ-British Medical Journal
- Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests
- (2016) Andrew J Vickers et al. BMJ-British Medical Journal
- A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
- (2016) Kjell Oberg et al. Endocrine Connections
- Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status
- (2015) Mark Kidd et al. ENDOCRINE-RELATED CANCER
- Specific efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced neuroendocrine tumours of the small intestine
- (2015) Amir Sabet et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
- (2015) L. Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Long-term results of PRRT in advanced bronchopulmonary carcinoid
- (2015) Annapaola Mariniello et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy
- (2015) Jarosław B. Ćwikła et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Biomarker: Predictive or Prognostic?
- (2015) Karla V. Ballman JOURNAL OF CLINICAL ONCOLOGY
- Validation of a Multiprotein Plasma Classifier to Identify Benign Lung Nodules
- (2015) Anil Vachani et al. Journal of Thoracic Oncology
- Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways
- (2015) Alessandro Valli et al. Oncotarget
- Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
- (2014) Samer Ezziddin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
- (2014) S. Ezziddin et al. JOURNAL OF NUCLEAR MEDICINE
- Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis
- (2013) J. Kaijser et al. HUMAN REPRODUCTION UPDATE
- Treatment with the Radiolabelled Somatostatin Analog177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
- (2013) Maddalena Sansovini et al. NEUROENDOCRINOLOGY
- Gastroenteropancreatic neuroendocrine neoplasms: Historical context and current issues
- (2013) Zhaohai Yang et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Peptide receptor radionuclide therapy of neuroendocrine tumors with 90Y-DOTATOC: Is treatment response predictable by pre-therapeutic uptake of 68Ga-DOTATOC?
- (2013) M.Ö. Öksüz et al. Diagnostic and Interventional Imaging
- Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver
- (2011) Zhaohai Yang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Decreased expression of genes involved in oxidative phosphorylation in human pancreatic islets from patients with type 2 diabetes
- (2011) Anders H Olsson et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
- (2011) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
- (2011) Anna Imhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Response and Long-Term Control of Bone Metastases After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
- (2011) S. Ezziddin et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine Tumors
- (2010) A. R. Haug et al. JOURNAL OF NUCLEAR MEDICINE
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- (2009) Dik J Kwekkeboom et al. ENDOCRINE-RELATED CANCER
- 68Ga-DOTA-Tyr3-Octreotide PET for Assessing Response to Somatostatin-Receptor-Mediated Radionuclide Therapy
- (2009) M. Gabriel et al. JOURNAL OF NUCLEAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now